These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23307426)

  • 1. 3-[(6-Arylamino)pyridazinylamino]benzoic acids: design, synthesis and in vitro evaluation of anticancer activity.
    Abouzid KA; Khalil NA; Ahmed EM; Mohamed KO
    Arch Pharm Res; 2013 Jan; 36(1):41-50. PubMed ID: 23307426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and cytotoxic evaluation of some new phthalazinylpiperazine derivatives.
    Liu Y; Zhang S; Li Y; Wang J; Song Y; Gong P
    Arch Pharm (Weinheim); 2012 Apr; 345(4):287-93. PubMed ID: 22006840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anticancer activities of new 3-allylthio-6-(mono or disubstituted)aminopyridazines.
    Won YH; Park MS
    Arch Pharm Res; 2010 Feb; 33(2):189-96. PubMed ID: 20195817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor activities of novel 1,4-disubstituted phthalazine derivatives.
    Zhang S; Zhao Y; Liu Y; Chen D; Lan W; Zhao Q; Dong C; Xia L; Gong P
    Eur J Med Chem; 2010 Aug; 45(8):3504-10. PubMed ID: 20537434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 4-oxo-3,4-dihydrophthalazine-1-carboxamide moieties as c-Met kinase inhibitors.
    Liu Z; Wang R; Guo R; Hu J; Li R; Zhao Y; Gong P
    Bioorg Med Chem; 2014 Jul; 22(14):3642-53. PubMed ID: 24882675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in-vitro cytotoxic evaluation of novel pyridazin-4-one derivatives.
    Mojahidi S; Rakib el M; Sekkak H; Abouricha S; Benchat N; Mousse HA; Zyad A
    Arch Pharm (Weinheim); 2010 May; 343(5):310-3. PubMed ID: 20222064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors.
    Elagawany M; Ibrahim MA; Ali Ahmed HE; El-Etrawy ASh; Ghiaty A; Abdel-Samii ZK; El-Feky SA; Bajorath J
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2007-13. PubMed ID: 23453843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents.
    Zhou S; Liao H; He C; Dou Y; Jiang M; Ren L; Zhao Y; Gong P
    Eur J Med Chem; 2014 Aug; 83():581-93. PubMed ID: 24996144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cytotoxicity studies of novel 2-Hydrazonylpyrido[2,3-b]pyrazin-3(4H)-ones.
    Zhang G; Liu Y; Wang S; Zhou C; Huang Q; Gong P
    Arch Pharm (Weinheim); 2012 Jan; 345(1):49-56. PubMed ID: 21953529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer activity of Indolin-2-one derivatives bearing the 4-thiazolidinone moiety.
    Wang S; Zhao Y; Zhu W; Liu Y; Guo K; Gong P
    Arch Pharm (Weinheim); 2012 Jan; 345(1):73-80. PubMed ID: 21932254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cytotoxicity evaluation of substituted pyridazino[4,5-b]phenazine-5,12-diones and tri/tetra-azabenzofluorene-5,6-diones.
    Lee HJ; Kim JS; Suh ME; Park HJ; Lee SK; Rhee HK; Kim HJ; Seo EK; Kim C; Lee CO; Park Choo HY
    Eur J Med Chem; 2007 Feb; 42(2):168-74. PubMed ID: 17070967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives.
    Popovici L; Amarandi RM; Mangalagiu II; Mangalagiu V; Danac R
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):230-243. PubMed ID: 30734610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones.
    Rathish IG; Javed K; Ahmad S; Bano S; Alam MS; Akhter M; Pillai KK; Ovais S; Samim M
    Eur J Med Chem; 2012 Mar; 49():304-9. PubMed ID: 22305543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
    Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights.
    Sabt A; Eldehna WM; Al-Warhi T; Alotaibi OJ; Elaasser MM; Suliman H; Abdel-Aziz HA
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1616-1630. PubMed ID: 32781872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Synthesis of Pyridazine Containing Compounds with Promising Anticancer Activity.
    Elmeligie S; Ahmed EM; Abuel-Maaty SM; Zaitone SA; Mikhail DS
    Chem Pharm Bull (Tokyo); 2017; 65(3):236-247. PubMed ID: 28250345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of novel rhodanine-containing sorafenib analogs as potential antitumor agents.
    Li W; Zhai X; Zhong Z; Li G; Pu Y; Gong P
    Arch Pharm (Weinheim); 2011 Jun; 344(6):349-57. PubMed ID: 21433057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines.
    Onnis V; Cocco MT; Fadda R; Congiu C
    Bioorg Med Chem; 2009 Sep; 17(17):6158-65. PubMed ID: 19679483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.